Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kirova

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 11, 2023
Long-term efficacy and tolerance of a technique for postmastectomy electron beam radiation therapy of the unreconstructed chest wall and lymph node areas for non-metastatic breast cancersS Souidi, P Loap, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 2020
Institut Curie guidelines on breast target volume delineation for patients treated in lateral positionR Msika, A Fourquet, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2023
Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devicesC Petit, A Escande, T Sarrade, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 8, 2023
Radiation therapy of the primary tumour and oligometastatic sites in patients with breast cancer with synchronous metastases: A literature reviewR Le Scodan, Y Ghannam, Y Kirova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 29, 2026
Effective Dose to Immune Cells (EDIC) Predicts Event-free Survival in Triple-Negative Breast Cancer Treated With Helical TomotherapyP Loap, C Fouillade, L De Marzi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2001
[Hodgkin's disease: from gross tumor volume to clinical target volume, firm data and unresolved problems]J L Lagrange, Y Kirova, J P Le Bourgeois, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy and pregnancyM Michalet, C Dejean, U Schick, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 8, 2008
[Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?]A Fourquet, Y Kirova, M-A Bollet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 25, 2020
Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-upY Kirova, A Tallet, M C Aznar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2021
In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cellsF Mignot, Y Kirova, P Verrelle, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 11, 2023
Long-term efficacy and tolerance of a technique for postmastectomy electron beam radiation therapy of the unreconstructed chest wall and lymph node areas for non-metastatic breast cancersS Souidi, P Loap, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 2020
Institut Curie guidelines on breast target volume delineation for patients treated in lateral positionR Msika, A Fourquet, F Laki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2023
Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devicesC Petit, A Escande, T Sarrade, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 8, 2023
Radiation therapy of the primary tumour and oligometastatic sites in patients with breast cancer with synchronous metastases: A literature reviewR Le Scodan, Y Ghannam, Y Kirova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 29, 2026
Effective Dose to Immune Cells (EDIC) Predicts Event-free Survival in Triple-Negative Breast Cancer Treated With Helical TomotherapyP Loap, C Fouillade, L De Marzi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2001
[Hodgkin's disease: from gross tumor volume to clinical target volume, firm data and unresolved problems]J L Lagrange, Y Kirova, J P Le Bourgeois, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Radiotherapy and pregnancyM Michalet, C Dejean, U Schick, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 8, 2008
[Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?]A Fourquet, Y Kirova, M-A Bollet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 25, 2020
Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-upY Kirova, A Tallet, M C Aznar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2021
In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cellsF Mignot, Y Kirova, P Verrelle, et al.
Pageof 8